Characterizing the Response of Immune Cells Treated with Novel Anti-Schistosomal Compound
Advisor Information
Paul H. Davis
Location
MBSC Dodge Room 302B - U
Presentation Type
Oral Presentation
Start Date
4-3-2022 10:45 AM
End Date
4-3-2022 12:00 PM
Abstract
Schistosomiasis is a condition caused by a parasitic worm infection that predominantly affects third world countries. However, this parasite is currently untreatable in its juvenile form; thus, there is a clear and pressing need to develop a treatment for this affliction. There has been a novel compound developed (CS01) that has efficacy against all stages of worm infection; yet, the method of action is unknown. To characterize the response of our novel compound, we performed a series of assays to quantify how the compound affects the cellular ability to perform phagocytosis, and how this compound affects the transcriptional state of neutrophils using qPCR.
Scheduling Link
1
Characterizing the Response of Immune Cells Treated with Novel Anti-Schistosomal Compound
MBSC Dodge Room 302B - U
Schistosomiasis is a condition caused by a parasitic worm infection that predominantly affects third world countries. However, this parasite is currently untreatable in its juvenile form; thus, there is a clear and pressing need to develop a treatment for this affliction. There has been a novel compound developed (CS01) that has efficacy against all stages of worm infection; yet, the method of action is unknown. To characterize the response of our novel compound, we performed a series of assays to quantify how the compound affects the cellular ability to perform phagocytosis, and how this compound affects the transcriptional state of neutrophils using qPCR.